BiotechTube
GenoSpace

GenoSpace

Cambridge, United States· Est.
genospace.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $6.2M

Overview

Genospace is a private, revenue-generating software company founded in 2010 and headquartered in Cambridge, Massachusetts. It provides a data integration and analytics platform focused on oncology, enabling community-based clinics and research sites to match patients to complex biomarker-driven clinical trials, automate data workflows, and assess study feasibility. The company reports its technology is used by over 500 sites, reaching 1 in 5 U.S. cancer patients, and has facilitated a more than 50% increase in trial enrollments for its users. Its business model is centered on a software-as-a-service (SaaS) platform and related services for the clinical research and care ecosystem.

Oncology

Technology Platform

A cloud-based software platform that integrates and analyzes clinical, genomic, and real-world data to enable clinical trial matching, EMR-to-EDC data automation, and study feasibility assessments for precision medicine, primarily in oncology.

Funding History

2
Total raised:$6.2M
Series A$5M
Seed$1.2M

Opportunities

The growing complexity of biomarker-driven oncology trials creates a large, sustained demand for efficient patient matching and site selection tools, especially in the underserved community practice setting.
Furthermore, the platform's aggregation of real-world clinical and genomic data represents a valuable asset for generating real-world evidence, which is increasingly demanded by regulators, payers, and biopharma companies for market access and research.

Risk Factors

The company operates in a competitive landscape with both large CROs and specialized software firms.
Its success is heavily dependent on seamless integration with diverse EMR systems and genomic test providers, which is technically challenging.
As a custodian of sensitive patient data, it faces significant regulatory (HIPAA) and cybersecurity risks that could impact its reputation and operations.

Competitive Landscape

Genospace competes in the clinical trial enablement and oncology data platform space. Competitors include large Contract Research Organizations (CROs) like IQVIA and Parexel with their own technology suites, specialized clinical trial management software companies, and oncology-focused real-world data platforms like Flatiron Health (owned by Roche). Its differentiation lies in its specific focus on bridging community-based clinical care with research through integrated workflow tools.

More companies in Diagnostics & Precision Medicine →More companies in United States →